The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 519-523

  Horwitz, Eric M ^a   Hanlon, Alexandra L ^a   Pinover, Wayne H ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Biochemical control; Prostate cancer; Prostate specific antigen; Radiation therapy; Stage T1c

Indexed keywords

BIOCHEMICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; RADIATION FIELD; RADIATION SICKNESS; SURVIVAL RATE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 0031801381     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00095-9     Document Type: Article

References (18)

1. Prostate. In: Bearhrs O.H., Henson D.R., Hutter R.V.P., Myers M.H. Manual for staging of cancer. 1988;177-182 JB Lippincott, Philadelphia.
2. Prostate. In: Beahrs O.H., Henson D.E., Hutter R.V.P., Kennedy B.J. Manual for the staging of cancer. 1992;181-186 JB Lippincott, Philadelphia.
3. Pinover W.H., Hanlon A.L., Lee W.R., Kaplan E.J., Hanks G.E. Prostate carcinoma patients upstaged by imaging and treated with irradiation. Cancer. 77:1996;1334-1341.
4. Hanks G.E., Lee W.R., Hanlon A.L., Hunt M., Kaplan E., Epstein B.E., Movsas B., Schultheiss T.E. Conformal technique for dose escalation for prostate cancer Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;861-868.
5. Movsas B., Hanlon A.L., Teshima T., Hanks G.E. Analyzing predictive models following definitive radiotherapy for prostate carcinoma. Cancer. 80:1997;1093-1102.
6. Consensus statement Guidelines for PSA following radiation therapy . Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1035-1041.
7. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
8. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:1959;719-748.
9. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-220.
10. Schultheiss T.E., Lee W.R., Hunt M.A., Hanlon A.L., Peter R.S., Hanks G.E. Late GI and GU complications in the treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;3-11.
11. Pound C.R., Partin A.W., Epstein J.I., Walsh P.C. PSA following anatomical radical retropubic prostatectomy An interim report . Urol. Clin. North Am. 24:1997;395-406.
12. Lerner S.E., Seay T.M., Blute M.L., Bergstrahl E.J., Barrett D., Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c) An interim analysis . J. Urol. 155:1996;821-826.
13. Blasko J.C., Wallner K., Grimm P.D., Ragde H. Prostate specific antigen based disease control following ultrasound guided 125 iodine implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154:1995;1096-1099.
14. Leibel S.A., Zelefsky M.J., Kutcher G.J., Burman C.M., Kelson S., Fuks Z. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate Interim report of a phase I dose-escalation study . J. Urol. 152:1994;1792-1798.
15. Zagars G.K., Geara F.B., Pollack A., von Eschenbach A.C. The T classification of clinically localized prostate cancer An appraisal based on disease outcome after radiation therapy . Cancer. 73:1994;1904-1912.
16. Horwitz E.M., Vicini F.A., Ziaja E.L., Gonzalez J., Dmuchowski C.F., Stromberg J.S., Brabbins D.S., Hollander J., Chen P.Y., Martinez A.A. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;565-571.
17. Epstein J.I., Walsh P.C., Carmichael M., Brendler C.B. Radical prostatectomy for nonpalpable prostate cancer (stage T1c) Pathological and clinical findings . JAMA. 271:1994;368-374.
18. Partin A.W., Kattan M.W., Subong E.N.P., Walsh P.C., Wojno K.J., Oesterling J.E., Scardino P.T., Pearson J.D. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer A multi-institutional update . JAMA. 277:1997;1445-1451.